APROCITENTAN (is an active metabolite) | APROCITENTAN | ATC C02KN01
CARDIOVASCULAR ANTIHYPERTENSIVE PULMONARY ARTERIAL HYPERTENSION (PAH) ENDOTHELIN RECEPTOR ANTAGONIST ET-1 PREVENTS THE BINDING OF ET-1 TO ITS RECEPTORS ETA AND ETB METABOLITE 20 PERCENT AS POTENT AS THE PARENT DRUG IN VITRO | ORAL | Cmax 2.38 MICROMOLAR Tmax 4.5 HOUR VD 20 LITER PPB 99 PERCENT Cl 0.3 LITER / HOUR HT 41 HOUR SOLUBILITY INSOLUBLE IN WATER | ENDOTHELIN RECEPTOR ET-1 | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |